But Sen. Sanders scored a win on Friday, as the CEO of Novo Nordisk, the maker of Ozempic, agreed to testify about the prices he’s charging consumers.
Sen. Sanders is chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), where he’s been investigating Big Pharma and the prices that Americans are forced to pay for drugs that have been used in recent years for weight loss like Ozempic and Wegovy.
“I enjoyed the opportunity of chatting with Mr. Jørgensen this afternoon and thank him for agreeing to voluntarily testify on a solo panel before the HELP Committee on the high cost of Ozempic and Wegovy in the United States,” Sen. Sanders said in a press release.
“Novo Nordisk currently charges Americans with Type 2 diabetes $969 a month for Ozempic, while this same exact drug can be purchased for just $155 in Canada and just $59 in Germany.
Novo Nordisk also charges Americans with obesity $1,349 a month for Wegovy, while this same exact product can be purchased for just $140 in Germany and $92 in the United Kingdom.”
The Inflation Reduction Act passed in 2022 will now allow Medicare to negotiate on just 10 drugs, but Big Pharma has been fighting that modest change in court.
The original article contains 432 words, the summary contains 210 words. Saved 51%. I’m a bot and I’m open source!
This is the best summary I could come up with:
But Sen. Sanders scored a win on Friday, as the CEO of Novo Nordisk, the maker of Ozempic, agreed to testify about the prices he’s charging consumers.
Sen. Sanders is chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), where he’s been investigating Big Pharma and the prices that Americans are forced to pay for drugs that have been used in recent years for weight loss like Ozempic and Wegovy.
“I enjoyed the opportunity of chatting with Mr. Jørgensen this afternoon and thank him for agreeing to voluntarily testify on a solo panel before the HELP Committee on the high cost of Ozempic and Wegovy in the United States,” Sen. Sanders said in a press release.
“Novo Nordisk currently charges Americans with Type 2 diabetes $969 a month for Ozempic, while this same exact drug can be purchased for just $155 in Canada and just $59 in Germany.
Novo Nordisk also charges Americans with obesity $1,349 a month for Wegovy, while this same exact product can be purchased for just $140 in Germany and $92 in the United Kingdom.”
The Inflation Reduction Act passed in 2022 will now allow Medicare to negotiate on just 10 drugs, but Big Pharma has been fighting that modest change in court.
The original article contains 432 words, the summary contains 210 words. Saved 51%. I’m a bot and I’m open source!